Heart Failure

Dr Jay Edelberg: Mavacamten for HCM May Help to Reduce Health Care Resource Utilization

June 11th 2021, 11:00am


Patients with obstructive hypertrophic cardiomyopathy (HCM) use significant health care resources, and mavacamten can help to reduce their symptoms and improve their function, noted Jay Edelberg, MD, PhD, head of Heart Failure and Cardiomyopathy Development at Bristol Myers Squibb.

Elderly Patients With Heart Failure May Benefit From Progressive Rehabilitation

June 8th 2021, 6:41pm


Progressive rehabilitation produced superior results among patients randomized to a 36-session program during or following hospitalization for acute decompensated heart failure vs those randomized to usual care.

Dr Mariana Garcia: We Need to Address the Lack of Women Leaders in Guideline Creation and Clinical Trial Leadership

June 5th 2021, 11:30am


Barriers to authorship and adequate representation of women in heart failure–focused clinical trials need to be addressed, noted Mariana Garcia, MD, cardiology fellow in the Academic Clinical Investigator Pathway at Emory University and member of T32, Multidisciplinary Research Training to Reduce Inequalities in Cardiovascular Health (METRIC).

Dapagliflozin Shown to Be Cost-effective Among Patients With HFrEF

June 2nd 2021, 6:48pm


Data from the DAPA-HF trial and published literature show intermediate-level cost-effectiveness of dapagliflozin use among patients with heart failure with reduced ejection fraction (HFrEF).

Dr Deepak L. Bhatt: Vascepa Safe to Use Among Patients With Well-Controlled AFib

May 28th 2021, 12:00pm


The increase in hospitalization risk seen with Vascepa was small vs the survival gains seen from decreased rates of heart attack, stroke, and revascularization, noted Deepak L. Bhatt, MD, MPH, Brigham and Women’s Hospital Heart & Vascular Center.

Possible Link Seen Between Pericardial Fat, Heart Failure Risk

May 24th 2021, 6:00pm


Mount Sinai research released today shows a possible link between excess pericardial fat and greater risk of heart failure, with implications for early intervention and prevention of heart disease.

Heart Failure Beat: HFrEF and CKD, Pirfenidone Use in HFpEF, and More

May 21st 2021, 5:00pm


The latest coverage in the heart failure space from across MJH Life Sciences™.

Dr James Januzzi: AI Gives Us the Chance to Explore Care-Improvement Opportunities

May 18th 2021, 4:10pm


We want to use artificial intelligence (AI) to promote the best-case scenario in patient care, emphasized James Januzzi, MD, staff cardiologist at Massachusetts General Hospital.

AHF Management Among Elderly, Super-Elderly Needs Improvement in Japan

May 15th 2021, 12:30pm


Rates of acute heart failure (AHF) have recently been rapidly increasing among elderly and super-elderly patients in Japan, and this study investigated rates of all-cause death and mode of death among this patient population.

Studies With Potential to Change the Science of Heart Failure Management

May 14th 2021, 1:00pm


These 4 studies were pegged as “ones to watch” during the American College of Cardiology (ACC) annual briefing on results for consumers. They will be presented in the opening session of late-breaking clinical trial results on day 1 of ACC.21.